Healthcare -
Biotechnology - NASDAQ - US
$ 54.25
4.85 %
$ 2.07 B
Market Cap
-14.47
P/E
TARS - STOCK-BASED COMPENSATION
Stock-based Compensation TARS - Tarsus Pharmaceuticals, Inc.
19.8 M
LAST VALUE
53.15%
2 YEAR CAGR
366.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR